Post by
XeniaTechie on May 26, 2023 3:00pm
Chris discusses recent notice of allowance
Exciting news from Algernon Pharmaceuticals as they’ve made significant progress in drug development while securing additional funding. Recent NOA from USPTO and successful rights offering further validate their model focusing on repurposing drugs and protecting IP.